Kirk Ways

Insider

First SEC filing: June 25, 2021 · Latest: June 25, 2021

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 + 3 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
May 25, 2023	SPRB	A	30,000	—	—	30,000 Direct	—	Acquired	(price as of 2026-08-19)
May 25, 2022	SPRB	A	20,625	—	—	20,625 Direct	—	Acquired	(price as of 2026-08-19)
June 23, 2021	SPRB	A	20,000	—	—	20,000 Direct	—	Acquired	(price as of 2026-08-19)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
May 25, 2023	SPRB	Stock Option (Right to Buy)	Common Stock (30,000)	$2.26	May 24, 2033	30,000	Acquired
May 25, 2022	SPRB	Stock Option (Right to Buy)	Common Stock (20,625)	$1.32	May 24, 2032	20,625	Acquired
June 23, 2021	SPRB	Stock Option (Right to Buy)	Common Stock (20,000)	$10.55	June 22, 2031	20,000	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Matched by name from proxy statements (DEF 14A) — verify against the filing.

M.D., Ph.D.Interim Chief Medical Officer (5)

Fiscal year	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension change	Other	Total
2025	—	—	$442,050	$5,529	—	—	$596,833	$1,044,412

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.